{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:10:25Z","timestamp":1790637025514,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022XD023"],"award-info":[{"award-number":["2022XD023"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174250"],"award-info":[{"award-number":["82174250"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.numecd.2024.10.019","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:26:53Z","timestamp":1730093213000},"page":"103781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Association between systemic inflammation markers and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Ziqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-0289","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9142-0648","authenticated-orcid":false,"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.numecd.2024.10.019_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.numecd.2024.10.019_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.numecd.2024.10.019_bib3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.numecd.2024.10.019_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.numecd.2024.10.019_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.numecd.2024.10.019_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cgh.2023.09.018","article-title":"Longitudinal outcomes associated with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of 129 studies","volume":"22","author":"Chan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.numecd.2024.10.019_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.numecd.2024.10.019_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.numecd.2024.10.019_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"S\u00f6derberg","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.numecd.2024.10.019_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12933-023-01998-y","article-title":"The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003-2016","volume":"22","author":"Dong","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.numecd.2024.10.019_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-024-02129-x","article-title":"Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry","volume":"23","author":"Luo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2024.10.019_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111575","article-title":"Association between inflammatory biomarkers and mortality in individuals with type 2 diabetes: NHANES 2005-2018","volume":"209","author":"Zhang","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2024.10.019_bib13","article-title":"Association between systemic inflammatory indicators with the survival of chronic kidney disease: a prospective study based on NHANES","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.numecd.2024.10.019_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2197652","article-title":"The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease","volume":"55","author":"Zhao","year":"2023","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.numecd.2024.10.019_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/17474124.2018.1463158","article-title":"The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review","volume":"12","author":"Peng","year":"2018","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.numecd.2024.10.019_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032313","article-title":"Overview of cellular and soluble mediators in systemic inflammation associated with non-alcoholic fatty liver disease","volume":"24","author":"Marques","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.numecd.2024.10.019_bib17","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.numecd.2024.10.019_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States national health and nutrition examination survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.numecd.2024.10.019_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.numecd.2024.10.019_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2024.10.019_bib21","article-title":"Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.numecd.2024.10.019_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12944-023-01947-4","article-title":"Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study","volume":"22","author":"Liu","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2024.10.019_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1554079","article-title":"Prognostic role of neutrophil to lymphocyte ratio in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"2022","author":"Shavakhi","year":"2022","journal-title":"Can J Gastroenterology Hepatology"},{"issue":"3","key":"10.1016\/j.numecd.2024.10.019_bib24","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1002\/cam4.5185","article-title":"Neutrophil-lymphocyte ratio in relation to risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease","volume":"12","author":"Thomas","year":"2023","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.numecd.2024.10.019_bib25","first-page":"278","article-title":"Neutrophil-lymphocyte ratio (NLR) could Be better predictor than C-reactive protein (CRP) for liver fibrosis in non-alcoholic steatohepatitis(NASH)","volume":"45","author":"Yilmaz","year":"2015","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.numecd.2024.10.019_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.numecd.2024.10.019_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.numecd.2024.10.019_bib28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.numecd.2024.10.019_bib29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"145","author":"Angulo","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.numecd.2024.10.019_bib30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2021.05.008","article-title":"Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease","volume":"75","author":"Younes","year":"2021","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.numecd.2024.10.019_bib31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","article-title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","volume":"8","author":"M\u00f3zes","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324004009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324004009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:37:43Z","timestamp":1762331863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324004009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0939475324004009"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.10.019","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between systemic inflammation markers and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103781"}}